SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640455-17-000026
Filing Date
2017-05-09
Accepted
2017-05-09 08:34:13
Documents
3
Period of Report
2017-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnce033120178k.htm 8-K 26081
2 EXHIBIT 99.1 jnce03312017exhibit991.htm EX-99.1 74632
3 jouncelogosmallera08.jpg GRAPHIC 44678
  Complete submission text file 0001640455-17-000026.txt   163306
Mailing Address 1030 MASSACHUSETTS AVE. CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVE. CAMBRIDGE MA 02138 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37998 | Film No.: 17824747
SIC: 2836 Biological Products, (No Diagnostic Substances)